Gupta Rishi has filed 14 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 33989 shares of Enliven Therapeutics, Inc. ($ELVN) on February 12, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Not found | A | Stock Option (right to buy) | 33989 | $0.00 | 33,989.0000 | 62,093,795 | 9999.99% | 0.05% |
| Feb. 12, 2026 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Not found | A | Stock Option (right to buy) | 1580 | $0.00 | 1,580.0000 | 62,093,795 | 9999.99% | 0.00% |
| Aug. 8, 2025 | Turnstone Biologics Corp. | $TSBX | Gupta Rishi | Not found | U | Common Stock | 3099265 | $0.00 | 0.0000 | 23,138,896 | 100.00% | 13.39% |
| Feb. 6, 2025 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Not found | A | Stock Option (right to buy) | 20491 | $0.00 | 20,491.0000 | 47,072,532 | 9999.99% | 0.04% |
| June 3, 2024 | Turnstone Biologics Corp. | $TSBX | Gupta Rishi | Not found | A | Stock Option (Right to Buy) | 12770 | $0.00 | 12,770.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | S | Common Stock | 33300 | $22.14 | 254,814.0000 | 35,546,215 | 11.56% | 0.09% |
| May 16, 2024 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | S | Common Stock | 1000000 | $22.14 | 7,663,349.0000 | 35,546,215 | 11.54% | 2.81% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Not found | A | Stock Option (right to buy) | 23364 | $0.00 | 23,364.0000 | 35,546,215 | 9999.99% | 0.07% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Not found | A | Stock Option (right to buy) | 16835 | $0.00 | 16,835.0000 | 35,546,215 | 9999.99% | 0.05% |
| May 17, 2023 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | M | Stock Options (Right to Buy) | 2125 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 17, 2023 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | M | Common Stock | 2125 | $4.28 | 8,951,463.0000 | 0 | 0.02% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | A | Stock Option (right to buy) | 27567 | $0.00 | 27,567.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | A | Common Stock | 288114 | $0.00 | 288,114.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Gupta Rishi | Director | A | Common Stock | 7611458 | $0.00 | 7,611,458.0000 | 0 | 9999.99% | 0.00% |